600557 康缘药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.81510.7929.5927.5686.490
总资产报酬率 ROA (%)2.0427.7156.7815.2824.300
投入资产回报率 ROIC (%)2.79810.5049.0636.8735.626

边际利润分析
销售毛利率 (%)74.60674.26972.09671.90672.899
营业利润率 (%)13.43611.58210.4539.62011.591
息税前利润/营业总收入 (%)12.39610.84510.0419.22210.449
净利润/营业总收入 (%)11.00611.23810.1578.8909.038

收益指标分析
经营活动净收益/利润总额(%)96.85092.17991.82794.374103.978
价值变动净收益/利润总额(%)3.3972.6850.9421.2360.921
营业外收支净额/利润总额(%)-2.811-2.325-2.040-6.920-19.359

偿债能力分析
流动比率 (X)2.4632.5172.0941.9781.701
速动比率 (X)2.2322.3001.9021.7461.479
资产负债率 (%)25.34724.40227.39625.67829.285
带息债务/全部投入资本 (%)-2.591-1.6132.9694.5279.736
股东权益/带息债务 (%)-3,846.751-6,149.7953,213.4042,064.423906.257
股东权益/负债合计 (%)284.758298.992255.353278.546232.540
利息保障倍数 (X)-18.435-22.894-49.43941.01014.152

营运能力分析
应收账款周转天数 (天)44.67551.10360.41383.245119.504
存货周转天数 (天)97.26399.581100.950125.488142.622